<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.cmi.2024.04.017</dc:identifier><dc:language>eng</dc:language><dc:creator>Rabodoarivelo, Marie Sylvianne</dc:creator><dc:creator>Gómez, Ana Belén</dc:creator><dc:creator>Picó Marco, Ana</dc:creator><dc:creator>Martín, Carlos</dc:creator><dc:creator>Ramón-García, Santiago</dc:creator><dc:title>Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method</dc:title><dc:identifier>ART-2024-138990</dc:identifier><dc:date>2024</dc:date><dc:source>http://zaguan.unizar.es/record/135987</dc:source><dc:doi>10.1016/j.cmi.2024.04.017</dc:doi><dc:identifier>http://zaguan.unizar.es/record/135987</dc:identifier><dc:identifier>oai:zaguan.unizar.es:135987</dc:identifier><dc:identifier.citation>Clinical Microbiology and Infection 30, 8 (2024), 1080-1082</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>